Sponsored by:

Molecular Imaging: Page 476

MDS Nordion gets FDA OK for TheraSphere clinical trials
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion reported that it has received U.S. Food and Drug Administration (FDA) approval to begin clinical trials of its TheraSphere treatment for liver cancer.
September 25, 2006
Advanced Medical Isotope buys Neu-Hope
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotope of Kennewick, WA, has acquired UTEK subsidiary Neu-Hope Technologies (NHT) in a stock transaction.
September 24, 2006
ART reorganizes for $6.6 million investment
By AuntMinnie.com staff writers
Canadian optical molecular imaging developer ART Advanced Research Technologies will receive $6.6 million (U.S.) from private investment firm Matco Capital of Calgary, Alberta, Canada, to recapitalize and reorganize ART's corporate structure.
September 21, 2006
Case Western to open molecular imaging research center
By AuntMinnie.com staff writers
Case Western Reserve University and the National Foundation for Cancer Research (NFCR) in Bethesda, MD, said they plan to establish a new NFCR Center for Molecular Imaging at the university's Cleveland campus.
September 21, 2006
Segami, Mid-Atlantic Imaging debut cardiac gamma camera
By AuntMinnie.com staff writers
Nuclear medicine software developer Segami and gamma camera developer Mid-Atlantic Imaging have released the maiCAM180, a portable, dual-detector gamma camera optimized for cardiac SPECT imaging in small office rooms and portable or mobile operations.
September 20, 2006
Cambridge Isotope acquires ABX
By AuntMinnie.com staff writers
Cambridge Isotope Laboratories (CIL) of Boston has acquired 100% of the stock of ABX Advanced Biochemical Compounds of Radeberg, Germany.
September 19, 2006
IBA shows financial gains in Q2
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Applications (IBA) posted gains in sales and earnings its mid-year financial report (end-June 30).
September 17, 2006
Dual-time-point PET spots local, distant breast metastases
By Jonathan S. Batchelor
Dual-time-point FDG-PET can aid in the differentiation of malignant from normal tissue in the breast, as well as in the detection of locoregional and distant metastasis from primary breast cancer, according to scientists from the Hospital of the University of Pennsylvania in Philadelphia. The technique involves scanning a patient at two distinct time intervals in order to quantify radiotracer uptake.
September 13, 2006
2006 09 13 11 08 40 706
Two studies define role of molecular imaging, therapy in endocrine carcinoma
By Shalmali Pal
Digestive endocrine tumors would seem to be as intricate as the digestive system itself, so it's no wonder that clinicians are searching for the best imaging modality to diagnose, differentiate, and treat endocrine tumors. Two recent studies looked at how molecular imaging and therapy fared in this disease. A group from Poland evaluated endocrine cancer response to treatment with a radiolabeled somatostatin analogue, while researchers in France tested two molecular imaging techniques in endocrine cancers as a tool for diagnosis and staging.
September 13, 2006
2006 09 13 10 17 51 706
Cell>Point names Rollo as president
By AuntMinnie.com staff writers
Radiopharmaceutical developer Cell>Point of Englewood, CO, has named former Philips Medical Systems chief medical officer Dr. David Rollo as its president.
September 12, 2006
Neoprobe, Estech expand distribution deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has expanded its distribution agreement with Estech of San Ramon, CA.
September 10, 2006
MDS Nordion Q3 posts flat revenues
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion reported no increase in revenues for its fiscal 2006 third quarter (end-July 31).
September 6, 2006
Previous Page
Page 476 of 611
Next Page